DJIA 17,938.59 133.79 0.75%
NASDAQ 4,780.14 14.76 0.31%
S&P 500 2,077.04 6.39 0.31%
market minute promo

Amarin Corp plc (ADR) (NASDAQ: AMRN)

1.06 -0.07 (-6.19%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMRN $1.06 -6.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.13
Previous Close $1.13
Daily Range $1.06 - $1.19
52-Week Range $0.78 - $2.75
Market Cap $185.1M
P/E Ratio -2.22
Dividend (Yield) $0.00 (0.0%)
Volume 1,133,973
Average Daily Volume 1,992,440
Current FY EPS -$0.47





Amarin Corp plc (ADR) (AMRN) Description

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders. Website:

News & Commentary Rss Feed

Why Amarin Corporation PLC Stock Flew 37% Higher in November

Amarin shares rocket higher in November after the company released exciting new data on Vascepa. But will it be enough to sustain the rally more than a few weeks?

Good News: Vascepa Kept Its Place On National Formularies

Amarin Corporation: Upside Becomes Clearer While The Path To The Finish Line Remains Murky

Amarin: The Silence Of The Lamb

Update: Amarin Earnings Show It Blew Its Chance At 2014 Profitability

Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4% - Tale of the Tape

Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind

Update: Amarin's Q3 2014 Earnings Report

Amarin's Value With Or Without REDUCE-IT And A Final Word On Management

Update: Amarin Announces Its Q3 2014 Cash Balance

See More AMRN News...

AMRN's Top Competitors

AMRN $1.06 (-6.19%)
Current stock: AMRN
JNJ $106.68 (1.07%)
Current stock: JNJ
NVS $95.25 (0.68%)
Current stock: NVS
RHHBY $34.69 (0.64%)
Current stock: RHHBY